Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission

Abstract

Although rare, clinically relevant progression of joint damage does occur in patients with RA in prolonged remission. This suggests the need for markers that predict progression during periods of low disease activity and for drugs that prevent damage that is independent of disease activity.